跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TIDOMET FORTE TABLET - HSA Drug Approval Details
Approvals
/
HSA
/
TIDOMET FORTE TABLET
Approved
THERAPEUTIC
TIDOMET FORTE TABLET
TORRENT PHARMACEUTICALS LTD (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Jul 31, 2004
Approval ID
63cf8e48e08a04a0
Company
TORRENT PHARMACEUTICALS LTD (INDIA)
Type
Therapeutic
Approval Details
Approval Id
63cf8e48e08a04a0
Drug Name
TIDOMET FORTE TABLET
Product Name
TIDOMET FORTE TABLET
Approval Number
SIN12575P
Approval Date
2004-07-31
Registrant
ZYFAS PHARMA PTE LTD
Licence Holder
ZYFAS PHARMA PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
N04BA02
Atc Item Name
levodopa and decarboxylase inhibitor
Pharma Manufacturer Name
ZYFAS PHARMA PTE. LTD.
Company Detail Path
/organization/zyfas-pharma-pte-ltd
Active Ingredients
CARBIDOPA ANHYDROUS
25 mg
LEVODOPA
250 mg
CARBIDOPA ANHYDROUS
25 MG
LEVODOPA
250 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 31, 2004
Approval ID
63cf8e48e08a04a0
Type
Therapeutic
Back to HSA Approvals